Topics

Pharmaceutical Industry
Few Allergan execs to keep top jobs in Actavis takeover
Few Allergan execs to keep top jobs in Actavis takeover

The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO. Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the second quarter of 2015, ending decades of local ownership at the Irvine firm. On Tuesday, Actavis said its current chief executive, Brent Saunders, would keep the top post at the combined company. In a statement, Saunders said Allergan President Douglas Ingram would become his special advisor. No other Allergan executive committee members were given senior leadership roles. Actavis spokesman David Belian declined to say whether...

Loading